Announcements Trials
Browse Landscape

Phase

Phase 3 2Phase 1 2Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

CNS 2Sarcoma 1

Conditions

Glioblastoma 2Neoplasms 1Gliosarcoma 1Brain Neoplasms 1

Interventions

Radiotherapy 64Temozolomide 59Vincristine 33Cyclophosphamide 32Carboplatin 30Radiosurgery 26Etoposide 25Cisplatin 25Lomustine 24Magnetic Resonance Spectroscopy 19Filgrastim 17Doxorubicin 15Bevacizumab 15Radiation 13Specimen Handling 12Granulocyte Colony-Stimulating Factor 12Surgical Procedures, Operative 11Isotretinoin 11Melphalan 10Carmustine 10Procarbazine 9Platinum 9Peripheral Blood Stem Cell Transplantation 9Chemotherapy, Adjuvant 9etoposide phosphate 7Topotecan 71,2-diaminocyclohexaneplatinum II citrate 7sargramostim 6Thiotepa 6Radiotherapy, Intensity-Modulated 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 3 × depatuxizumab mafodotin × CNS × Clear all
NCT02573324 2023-05-11

Intellance1

AbbVie

Phase 3 Completed
691 enrolled 28 charts
CNSSarcoma

Brain Neoplasms, Glioblastoma, Gliosarcoma

NCT03419403 2021-04-14

UNITE Study: Understanding New Interventions With GBM ThErapy

AbbVie

Phase 3 Terminated
40 enrolled 16 charts
CNS

Glioblastoma, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡